Litcius/Paper detail

Tumor infiltrating lymphocytes after neoadjuvant IRX-2 immunotherapy in oral squamous cell carcinoma: Interim findings from the INSPIRE trial

Gregory T. Wolf, Siyu Liu, Emily Bellile, Maureen A. Sartor, Laura S. Rozek, Dafydd Thomas, Ariane Nguyen, Katie R. Zarins, Jonathan B. McHugh, Jeff Moyer, Mihir R. Patel, Nabil F. Saba, Audrey Erman, Wanessa A. Martins, Jason G. Newman, Michael J. Kaplan, Frabicio Oliveira, Ana Paula Victorina, R. Bryan Bell, Gustavo Girotto, Jorge J. Nieva, Joseph Valentino, Greg A. Krempl, Cláudio Roberto Cernea, Dennis H. Kraus, Kevin Higgins, Felipe José Silva Melo Cruz, Aru Panwar, Clodoaldo Zago Campos, Jim McCaul

2020Oral Oncology22 citationsDOI

Topics & Concepts

InterimMedicineImmunotherapyBasal cellOncologyInterim analysisInternal medicineClinical trialCancerHistoryArchaeologyCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesImmunotherapy and Immune Responses
Tumor infiltrating lymphocytes after neoadjuvant IRX-2 immunotherapy in oral squamous cell carcinoma: Interim findings from the INSPIRE trial | Litcius